COVID-19-Associated Pulmonary Mucormycosis: An Underdiagnosed Entity with High Mortality.
作者信息
Muthu Valliappan, Agarwal Ritesh, Chakrabarti Arunaloke
机构信息
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
出版信息
Mycopathologia. 2022 Aug;187(4):405-406. doi: 10.1007/s11046-022-00638-5. Epub 2022 Jun 12.
Abstract
摘要
相似文献
1
COVID-19-Associated Pulmonary Mucormycosis: An Underdiagnosed Entity with High Mortality.
Mycopathologia. 2022 Aug;187(4):405-406. doi: 10.1007/s11046-022-00638-5. Epub 2022 Jun 12.
2
Pulmonary artery pseudoaneurysm due to COVID-19-associated pulmonary mucormycosis.
Eur Heart J. 2024 Aug 16;45(31):2896. doi: 10.1093/eurheartj/ehae355.
3
Cavitary pulmonary opacity in a diabetic patient.
Intern Med. 2012;51(15):2061-2. doi: 10.2169/internalmedicine.51.8000. Epub 2012 Aug 1.
4
Pseudoaneurysm of the pulmonary artery with massive haemoptysis due to an invasive pulmonary mucormycosis.
Thorax. 2016 Feb;71(2):199-200. doi: 10.1136/thoraxjnl-2015-207713. Epub 2015 Sep 18.
5
[Pulmonary mucormycosis with few symptoms in a patient with lung cancer].
Enferm Infecc Microbiol Clin. 1994 Jan;12(1):43-4.
6
Subcutaneous emphysema of the chest: could it be pulmonary mucormycosis?
Thorax. 2010 Mar;65(3):280. doi: 10.1136/thx.2009.115659.
7
Pulmonary mucormycosis.
J Assoc Physicians India. 1998 Apr;46(4):396-7.
8
Pulmonary mucormycosis diagnosed by bronchoalveolar lavage: a case report and review of the literature.
Pediatr Pulmonol. 1997 Mar;23(3):222-5. doi: 10.1002/(sici)1099-0496(199703)23:3<222::aid-ppul9>3.0.co;2-p.
9
Invasive pulmonary mucormycosis with concomitant lung cancer presented with massive hemoptysis by huge pseudoaneurysm of pulmonary artery.
Ann Thorac Surg. 2014 Nov;98(5):1832-5. doi: 10.1016/j.athoracsur.2013.12.051. Epub 2014 Oct 30.
10
Pulmonary mucormycosis in the setting of chronic obstructive pulmonary disease. A case report and review of the literature.
Respiration. 2002;69(6):560-3. doi: 10.1159/000066467.
引用本文的文献
1
Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India.
Emerg Infect Dis. 2023 Jan;29(1):8-19. doi: 10.3201/eid2901.220926.
2
COVID-19-Associated Pulmonary Mucormycosis.
J Fungi (Basel). 2022 Jul 5;8(7):711. doi: 10.3390/jof8070711.
本文引用的文献
1
Seroprevalences Against Paracoccidioides cetii: A Causative Agent for Paracoccidiomycosis Ceti (PCM-C) and Coccidioides posadasii; for Coccidioidomycosis (CCM) in Dall's Porpoise (Phocoenoides dalli) and Harbor Porpoise (Phocoena phocoena) Stranded at Hokkaido, Japan.
Mycopathologia. 2022 Aug;187(4):385-391. doi: 10.1007/s11046-022-00643-8. Epub 2022 Jun 8.
2
Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication.
Open Forum Infect Dis. 2021 Nov 6;9(2):ofab566. doi: 10.1093/ofid/ofab566. eCollection 2022 Feb.
3
Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.
Mycopathologia. 2022 Feb;187(1):31-37. doi: 10.1007/s11046-021-00610-9. Epub 2021 Dec 22.
4
Notes from the Field: Mucormycosis Cases During the COVID-19 Pandemic - Honduras, May-September 2021.
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1747-1749. doi: 10.15585/mmwr.mm7050a2.
5
CT Findings of COVID-19-associated Pulmonary Mucormycosis: A Case Series and Literature Review.
Radiology. 2022 Jan;302(1):214-217. doi: 10.1148/radiol.2021211583. Epub 2021 Aug 31.
6
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
Mycopathologia. 2021 Dec;186(6):739-754. doi: 10.1007/s11046-021-00584-8. Epub 2021 Aug 19.
7
Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis.
Clin Microbiol Infect. 2021 Apr;27(4):538-549. doi: 10.1016/j.cmi.2020.12.035. Epub 2021 Jan 5.
8
The Reversed Halo Sign and the Bronchus Sign: The Eyes See Only What the Mind Knows.
Ann Am Thorac Soc. 2019 Sep;16(9):1203. doi: 10.1513/AnnalsATS.201905-360LE.
Zotero 插件